Treatments of Idiopathic Granulomatous Mastitis

Comparison of three types of treatments in patients with Idiopathic Granulomatous Mastitis

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20160101025791N3

Enrollment

150

Registered

2019-03-04

Start date

2018-10-28

Completion date

Unknown

Last updated

2019-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Idiopathic Granulomatous Mastitis. Granulomatous disorders of skin and subcutaneous tissue

Interventions

Intervention 1: Group 1: Some doctors believe that the disease does not need to be treated at a warm, red, and massive stage, but if it leads to an abscess, it will empty the abscess and give antibiot

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Female patients Patients without systematic diseases

Exclusion criteria

Exclusion criteria: Pregnant women Women with a history of breast cancer in the family

Design outcomes

Primary

Measure	Time frame
Response to treatment. Timepoint: Before and after 6 months of intervention. Method of measurement: ELISA kit.	—

Secondary

Measure	Time frame
White blood cell. Timepoint: Before and after 6 months of intervention. Method of measurement: LeukoChek test kit.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMazaher Ramezani

Kermanshah University of Medical Sciences

Mazaher_ramezani@yahoo.com+98 83 3427 6300

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026